Full text is available at the source.
The TREM2-APOE Pathway Drives the Transcriptional Phenotype of Dysfunctional Microglia in Neurodegenerative Diseases
How the TREM2-APOE Pathway Shapes Dysfunctional Brain Immune Cells in Neurodegenerative Diseases
AI simplified
Abstract
A specific apolipoprotein E (APOE)-dependent molecular signature was identified in microglia from models of neurodegenerative disorders.
- Microglia lose their normal homeostatic function during neurodegenerative diseases such as amyotrophic lateral sclerosis (ALS), multiple sclerosis (MS), and Alzheimer's disease (AD).
- The transition to a neurodegenerative microglial phenotype is mediated by the APOE pathway after the uptake of dying neurons.
- TREM2 signaling is involved in inducing APOE signaling within microglia.
- Targeting the TREM2-APOE pathway may help restore the normal function of microglia in ALS and AD models and protect against neuronal loss.
- APOE-mediated neurodegenerative microglia appear to have lost their ability to maintain immune tolerance.
AI simplified